John Robertson, MD, BSc, FRCS

Conference Coverage

Optimal Camizestrant Dose for Patients With ER-Positive, HER2-Negative Primary Breast Cancer

12/08/2023

John Robertson MB chB BSc, MD, FRCS, shared results from the SERENA-3 trial, investigating the effect multiple doses of camizestrant at different treatment durations has on ER, ki-67, and PgR expression.

John Robertson MB chB BSc, MD,...

12/08/2023

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

See Full Calendar

John Robertson, MD, BSc, FRCS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products